238 related articles for article (PubMed ID: 29419652)
1. Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms.
Wahlman C; Doyle TM; Little JW; Luongo L; Janes K; Chen Z; Esposito E; Tosh DK; Cuzzocrea S; Jacobson KA; Salvemini D
Pain; 2018 Jun; 159(6):1025-1034. PubMed ID: 29419652
[TBL] [Abstract][Full Text] [Related]
2. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
Janes K; Wahlman C; Little JW; Doyle T; Tosh DK; Jacobson KA; Salvemini D
Brain Behav Immun; 2015 Feb; 44():91-9. PubMed ID: 25220279
[TBL] [Abstract][Full Text] [Related]
3. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
[TBL] [Abstract][Full Text] [Related]
4. Chronic Morphine-Induced Changes in Signaling at the A
Doyle TM; Largent-Milnes TM; Chen Z; Staikopoulos V; Esposito E; Dalgarno R; Fan C; Tosh DK; Cuzzocrea S; Jacobson KA; Trang T; Hutchinson MR; Bennett GJ; Vanderah TW; Salvemini D
J Pharmacol Exp Ther; 2020 Aug; 374(2):331-341. PubMed ID: 32434943
[TBL] [Abstract][Full Text] [Related]
5. Role of Adenosine Kinase in Sphingosine-1-Phosphate Receptor 1-Induced Mechano-Hypersensitivities.
Lauro F; Giancotti LA; Kolar G; Harada CM; Harmon TA; Garrett TJ; Salvemini D
Cell Mol Neurobiol; 2022 Nov; 42(8):2909-2918. PubMed ID: 34773542
[TBL] [Abstract][Full Text] [Related]
6. Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.
Little JW; Ford A; Symons-Liguori AM; Chen Z; Janes K; Doyle T; Xie J; Luongo L; Tosh DK; Maione S; Bannister K; Dickenson AH; Vanderah TW; Porreca F; Jacobson KA; Salvemini D
Brain; 2015 Jan; 138(Pt 1):28-35. PubMed ID: 25414036
[TBL] [Abstract][Full Text] [Related]
7. Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
Stockstill K; Wahlman C; Braden K; Chen Z; Yosten GL; Tosh DK; Jacobson KA; Doyle TM; Samson WK; Salvemini D
Pain; 2020 Jan; 161(1):177-184. PubMed ID: 31490328
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase 3 beta regulates glial glutamate transporter protein expression in the spinal dorsal horn in rats with neuropathic pain.
Weng HR; Gao M; Maixner DW
Exp Neurol; 2014 Feb; 252():18-27. PubMed ID: 24275526
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal interleukin-1β decreases sigma-1 receptor expression in spinal astrocytes in a murine model of neuropathic pain.
Choi SR; Han HJ; Beitz AJ; Lee JH
Biomed Pharmacother; 2021 Dec; 144():112272. PubMed ID: 34607109
[TBL] [Abstract][Full Text] [Related]
10. Activation of Sphingosine-1-Phosphate Receptor 1 in the Spinal Cord Produces Mechanohypersensitivity Through the Activation of Inflammasome and IL-1β Pathway.
Doyle TM; Chen Z; Durante M; Salvemini D
J Pain; 2019 Aug; 20(8):956-964. PubMed ID: 30802544
[TBL] [Abstract][Full Text] [Related]
11. TRAF6 upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-α and IL-1β signaling.
Lu Y; Jiang BC; Cao DL; Zhang ZJ; Zhang X; Ji RR; Gao YJ
Pain; 2014 Dec; 155(12):2618-2629. PubMed ID: 25267210
[TBL] [Abstract][Full Text] [Related]
12. Glial role in oxaliplatin-induced neuropathic pain.
Di Cesare Mannelli L; Pacini A; Micheli L; Tani A; Zanardelli M; Ghelardini C
Exp Neurol; 2014 Nov; 261():22-33. PubMed ID: 24967684
[TBL] [Abstract][Full Text] [Related]
13. Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway.
Mao XF; Wu HY; Tang XQ; Ali U; Liu H; Wang YX
J Neuroinflammation; 2019 Apr; 16(1):84. PubMed ID: 30981281
[TBL] [Abstract][Full Text] [Related]
14. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression.
Jung Y; Lee JH; Kim W; Yoon SH; Kim SK
BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201
[TBL] [Abstract][Full Text] [Related]
15. Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain.
Ford A; Castonguay A; Cottet M; Little JW; Chen Z; Symons-Liguori AM; Doyle T; Egan TM; Vanderah TW; De Koninck Y; Tosh DK; Jacobson KA; Salvemini D
J Neurosci; 2015 Apr; 35(15):6057-67. PubMed ID: 25878279
[TBL] [Abstract][Full Text] [Related]
16. Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity.
Yoon SY; Robinson CR; Zhang H; Dougherty PM
J Pain; 2013 Feb; 14(2):205-14. PubMed ID: 23374942
[TBL] [Abstract][Full Text] [Related]
17. The nitroxyl donor, Angeli's salt, reduces chronic constriction injury-induced neuropathic pain.
Longhi-Balbinot DT; Rossaneis AC; Pinho-Ribeiro FA; Bertozzi MM; Cunha FQ; Alves-Filho JC; Cunha TM; Peron JP; Miranda KM; Casagrande R; Verri WA
Chem Biol Interact; 2016 Aug; 256():1-8. PubMed ID: 27287419
[TBL] [Abstract][Full Text] [Related]
18. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
[TBL] [Abstract][Full Text] [Related]
19. Effects of intrathecal injection of rapamycin on pain threshold and spinal cord glial activation in rats with neuropathic pain.
Lv J; Li Z; She S; Xu L; Ying Y
Neurol Res; 2015 Aug; 37(8):739-43. PubMed ID: 26004146
[TBL] [Abstract][Full Text] [Related]
20. N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain.
Weyerbacher AR; Xu Q; Tamasdan C; Shin SJ; Inturrisi CE
Pain; 2010 Feb; 148(2):237-246. PubMed ID: 20005044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
